Publications

Show Filters

Searches all publications.

Search Fulltext

Publications

Section

Select publication to see the relevant sections.

Publication Date

    E.g., 2018-09-25
    E.g., 2018-09-25

Articles

14549 items
12:00 AM, Jan 15, 2009  |  BC Innovations | Targets & Mechanisms

Arresting infant retinopathy

Researchers at the Cleveland Clinic have found that activating hypoxia-inducible factor can prevent the progression of retinopathy in premature infants, which results in blindness if left unchecked. The findings, reported in the Proceedings of the...
12:00 AM, Jan 15, 2009  |  BC Innovations | Distillery Therapeutics

Indication: Ophthalmic disease

This week in therapeutics Indication Target/ marker/ pathway Summary Licensing status Publication and contact information Ophthalmic disease...
12:00 AM, Jan 15, 2009  |  BC Innovations | Distillery Therapeutics

Indication: Cancer

This week in therapeutics Indication Target/ marker/ pathway Summary Licensing status Publication and contact information Cancer ...
12:00 AM, Jan 15, 2009  |  BC Innovations | Distillery Therapeutics

Indication: Neurology

This week in therapeutics Indication Target/ marker/ pathway Summary Licensing status Publication and contact information Neurology ...
12:00 AM, Jan 15, 2009  |  BC Innovations | Distillery Therapeutics

Indication: Cancer

This week in therapeutics Indication Target/ marker/ pathway Summary Licensing status Publication and contact information Cancer ...
12:00 AM, Jan 15, 2009  |  BC Innovations | Distillery Techniques

Technology: Assays & screens

This week in techniques Approach Summary Licensing status Publication and contact information Assays & screens 3D microfluidic...
12:00 AM, Jan 15, 2009  |  BC Innovations | Targets & Mechanisms

Gift of the MAGL

A team at The Scripps Research Institute has developed the first specific monoacylglyceride lipase (MAGL) inhibitor, which should help determine whether this enzyme is a better pain target than the closely related fatty acid amide...
12:00 AM, Jan 15, 2009  |  BC Innovations | Targets & Mechanisms

Boosting hedgehog against IBD

Researchers at The University of Edinburgh have identified a reduced-function variant of a protein in the hedgehog signaling pathway that could be targeted to treat irritable bowel diseases, including ulcerative colitis.1 Although restoring the function...
12:00 AM, Jan 15, 2009  |  BC Innovations | Distillery Therapeutics

Indication: Cancer

This week in therapeutics Indication Target/ marker/ pathway Summary Licensing status Publication and contact information Cancer ...
12:00 AM, Jan 08, 2009  |  BC Innovations | Distillery Therapeutics

Indication: Neurology

This week in therapeutics Indication Target/marker/ pathway Summary Licensing status Publication and contact information Neurology ...

Pages